Loading
Morishita Jintan Co.,Ltd.: what insiders have been doing
We have very little insider data for Morishita Jintan Co.,Ltd. so far: the most recent filing dates from 29 July 2024. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Osaka Prefecture, Japan · Founded: 1936
Source: Wikidata (CC0).
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 8,479 of 24,148 companies
58.9
score / 100
Value61
Quality57
FCF yld-0.8%
Earn yld6.9%
EV/EBITDA7.9x
ROE6.3%
Gross mgn48%
Net mgn4.9%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥2,222
Analyst consensus
Income statement
RevenueJP¥12.7B
Gross profitJP¥6.1B48% margin
EBITDAJP¥1.4B11% margin
Net incomeJP¥628M6.2% margin
Valuation
PER (trailing)14.5x
P/Book0.7x
Beta0.01
Balance sheet & cash
Market capJP¥9.1B
Total debtJP¥1.8B
Free Cash Flow-JP¥77M
Debt / Equity13%
Profitability & ownership
ROE6.3%
ROA3.2%
% insiders46.3%
% institutions9.2%
Last declaration on 29 July 2024
Declarations1 total
ShareXTKSEDINET:S100U3FG
1 of 1 declaration
About Morishita Jintan Co.,Ltd.
Morisita Jintan Co., Ltd. is a Japanese company specializing in the production of pharmaceuticals and health products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.